Cite
Alencar AKN, Pimentel-Coelho PM, Montes GC, et al. Human Mesenchymal Stem Cell Therapy Reverses Su5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice. Front Pharmacol. 2018;9:1395doi: 10.3389/fphar.2018.01395.
Alencar, A. K. N., Pimentel-Coelho, P. M., Montes, G. C., da Silva, M. M. C., Mendes, L. V. P., Montagnoli, T. L., Silva, A. M. S., Vasques, J. F., Rosado-de-Castro, P. H., Gutfilen, B., Cunha, V. D. M. N., Fraga, A. G. M., Silva, P. M. R. E., Martins, M. A., Ferreira, T. P. T., Mendes-Otero, R., Trachez, M. M., Sudo, R. T., & Zapata-Sudo, G. (2018). Human Mesenchymal Stem Cell Therapy Reverses Su5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice. Frontiers in pharmacology, 91395. https://doi.org/10.3389/fphar.2018.01395
Alencar, Allan K N, et al. "Human Mesenchymal Stem Cell Therapy Reverses Su5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice." Frontiers in pharmacology vol. 9 (2018): 1395. doi: https://doi.org/10.3389/fphar.2018.01395
Alencar AKN, Pimentel-Coelho PM, Montes GC, da Silva MMC, Mendes LVP, Montagnoli TL, Silva AMS, Vasques JF, Rosado-de-Castro PH, Gutfilen B, Cunha VDMN, Fraga AGM, Silva PMRE, Martins MA, Ferreira TPT, Mendes-Otero R, Trachez MM, Sudo RT, Zapata-Sudo G. Human Mesenchymal Stem Cell Therapy Reverses Su5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice. Front Pharmacol. 2018 Dec 06;9:1395. doi: 10.3389/fphar.2018.01395. eCollection 2018. PMID: 30574088; PMCID: PMC6291748.
Copy
Download .nbib